cruzain
member
papaincathepsinl
famili
cystein
proteas
major
cystein
proteas
protozoan
trypanosoma
cruzi
caus
agent
chaga
diseas
report
autoinduct
methodolog
provid
solublecruzain
high
yield
mg
per
liter
minim
media
increas
yield
provid
suffici
quantiti
activ
enzym
use
nmrbase
ligand
map
use
cd
nmr
spectroscopi
also
examin
solutionst
structur
dynam
enzym
complex
coval
bound
vinyl
sulfon
inhibitor
report
backbon
amid
side
chain
carbon
chemic
shift
assign
cruzain
complex
reson
assign
use
identifi
map
residu
locat
substrat
bind
pocket
includ
catalyt
select
nci
nhi
cmet
label
perform
quickli
assess
cruzainligand
interact
set
eight
low
molecular
weight
compound
exhibit
micromolar
bind
inhibit
chemic
shift
perturb
map
verifi
six
eight
compound
bind
cruzain
activ
site
three
differ
bind
mode
delin
compound
name
coval
noncoval
noninteract
result
provid
exampl
nmr
spectroscopi
use
screen
compound
fast
evalu
enzymeinhibitor
interact
order
facilit
lead
compound
identif
subsequ
structur
studi
benznidazol
numer
deleteri
side
effect
avail
north
america
limit
quantiti
us
center
diseas
control
drug
gener
prescrib
earli
acut
stage
diseas
less
effect
treatment
chronic
condit
promis
target
potenti
therapeut
chaga
diseas
major
cystein
proteas
express
cruzi
cruzain
cruzain
member
papain
superfamili
cystein
proteas
sequenti
structur
homolog
cathepsin
l
case
chaga
diseas
cruzain
present
life
stage
trypanosom
implic
cellular
entri
digest
immunoglobin
activ
site
cruzain
contain
two
catalyt
residu
possibl
third
residu
contribut
proteolysi
sequenti
residu
number
instead
residu
number
match
papain
use
cruzain
throughout
report
fourth
residu
serv
stabil
oxyanion
similar
mani
cystein
proteas
famili
member
cruzain
initi
express
inact
zymogen
undergo
ph
temperatur
concentr
depend
selfactiv
transform
matur
catalyt
activ
proteas
one
lead
compound
target
matur
form
cruzain
current
preclin
trial
vinyl
sulfon
tabl
previous
design
inhibit
cruzain
irrevers
bind
thiol
group
catalyt
report
cure
cruziinfect
mice
shown
efficaci
multipl
strain
nifurtimoxand
benznidazoleresist
cruzi
valid
cruzain
therapeut
target
chaga
diseas
howev
limit
potenc
gener
interest
identifi
new
chemic
scaffold
effect
noncoval
competit
inhibitor
enzym
previou
structureact
relationship
sar
studi
focus
cruzaininhibitor
complex
histor
reli
xray
crystallographi
howev
due
concentrationdepend
selfproteolysi
apo
structur
activ
cruzain
current
avail
although
highthroughput
screen
effort
identifi
potenti
lead
compound
cruzaininhibitor
complex
yield
wellbehav
crystal
addit
previou
express
protocol
involv
product
cruzain
via
inclus
bodi
subsequ
unfold
refold
proteas
sever
limit
overal
yield
factor
mind
develop
express
purif
protocol
provid
suffici
quantiti
cruzain
nmr
studi
ii
use
nmrbase
method
quickli
verifi
map
bind
mode
newli
discov
inhibitor
especi
avail
crystallograph
data
iii
initi
solutionst
biophys
studi
gain
insight
apo
inhibit
cruzain
structurefunct
relationship
importantli
cruzain
serv
model
cystein
cathepsin
proteas
larg
famili
import
enzym
report
repres
first
nmr
studi
examin
solut
behavior
activ
cathepsin
llike
cystein
proteas
use
autoinduct
method
abl
increas
overal
yield
activ
matur
cruzain
greater
fold
origin
inclus
bodi
prepar
new
optim
protocol
also
enabl
express
isotop
label
sampl
nmr
studi
allow
us
obtain
backbon
side
chain
reson
assign
coval
inhibit
form
cruzain
assign
along
select
nci
nhi
cmet
cruzain
label
critic
map
character
inhibitor
bind
mode
eight
smallmolecul
inhibitor
includ
overal
result
describ
herein
provid
methodolog
rapidli
enhanc
understand
structurefunct
relationship
within
cystein
cathepsin
famili
gene
sequenc
encod
ctermin
truncat
procruzain
genbank
access
code
use
templat
construct
describ
studi
forward
primer
design
encod
ndei
restrict
site
follow
sequenc
bamhi
restrict
site
ntermin
procruzain
sequenc
start
cy
revers
primer
encod
termin
residu
follow
stop
codon
hindiii
restrict
site
primer
sequenc
integr
dna
technolog
inc
follow
forward
revers
result
oligonucleotid
encod
tag
procruzain
sequenc
ligat
vector
novagenemd
transform
arcticexpress
ril
compet
cell
agil
gene
verifi
dna
sequenc
result
protein
sequenc
display
figur
starter
cultur
use
express
tag
procruzain
consist
ml
luria
broth
contain
carbenicillin
gentamycin
hr
shake
overnight
lb
starter
cultur
ad
directli
l
autoinduct
minim
media
contain
baffl
l
shaker
flask
modifi
version
autoinduct
media
recip
use
uniform
nand
select
n
clabel
respect
case
uniform
nlabel
g
nh
cl
cambridg
isotop
laboratori
sigmaaldrich
per
liter
media
ad
case
select
label
three
separ
proteas
sampl
produc
ad
one
follow
one
liter
autoinduct
minim
media
mg
nci
cambridg
isotop
laboratori
ii
mg
n
ajinomoto
iii
mg
cmethyl
met
cambridg
isotop
laboratori
uniform
c
n
hlabel
modifi
version
autoinduct
media
recip
use
l
uniformli
c
n
hlabel
rich
media
e
cdn
silant
gmbh
dilut
l
cambridg
isotop
laboratori
split
l
aliquot
autoinduct
minim
media
solut
contain
carbenicillin
gentamycin
antibiot
specif
detail
regard
modif
standard
autoinduct
recip
report
support
inform
shake
approxim
hr
od
temperatur
reduc
cultur
allow
shake
addit
hr
cultur
centrifug
cell
pellet
store
readi
lysi
precondit
lb
starter
cultur
small
volum
ml
autoinduct
minim
media
overnight
tri
demonstr
ineffect
therefor
recommend
frozen
cell
pellet
thaw
resuspend
ml
lysi
buffer
per
l
express
media
lyse
via
sonic
sec
puls
follow
sec
recoveri
time
min
total
puls
time
lysi
buffer
consist
mm
tri
ph
mm
nacl
mm
imidazol
mm
cacl
mm
mgso
dnase
roch
mm
phenylmethanesulfonyl
fluorid
pmsf
mm
methyl
methanethiosulfon
mmt
pmsf
mmt
use
coval
cystein
proteas
inhibitor
revers
addit
dtt
result
lysat
centrifug
supernat
pass
filter
prior
fplc
purif
initi
purif
perform
use
two
ml
histrapff
crude
nickel
column
ge
healthcar
lifesci
attach
seri
follow
buffer
use
washbind
mm
tri
ph
mm
nacl
mm
imidazol
elut
mm
tri
ph
mm
nacl
mm
imidazol
elut
occur
elut
buffer
mmt
mm
final
concentr
ad
fraction
contain
tag
procruzain
upon
elut
column
major
fraction
combin
dialyz
activ
buffer
mm
acet
ph
mm
nacl
mm
edta
contain
reduc
agent
overnight
dialysi
result
cloudi
solut
transfer
ml
conic
centrifug
tube
autoproteolysi
proregion
kda
zymogen
kda
initi
ad
dtt
mm
final
concentr
solut
incub
water
bath
transform
inact
zymogen
catalyt
activ
domain
cruzain
kda
monitor
remov
aliquot
solut
select
time
point
sampl
analyz
either
sdspage
denatur
condit
figur
via
fluorescencebas
activ
assay
use
peptid
substrat
zpheargamc
biotium
inc
total
reaction
time
process
procruzain
activ
cruzain
gener
minut
indic
solut
becom
clear
longer
activ
time
hr
requir
complet
proteolyz
smaller
prodomain
fragment
prevent
degrad
matur
cruzain
reaction
quench
place
sampl
tube
ice
ad
mmt
mm
final
concentr
solut
next
buffer
exchang
pb
ph
second
round
fplc
purif
perform
use
preparativescal
size
exclus
column
ge
healthcar
lifesci
fplc
buffer
use
purif
round
contain
reduc
agent
unless
otherwis
specifi
mmt
mm
final
concentr
ad
major
fraction
immedi
upon
elut
column
fraction
collect
flash
frozen
store
readi
use
sampl
buffer
exchang
pb
ph
nmr
buffer
prior
data
acquisit
standard
nmr
buffer
consist
mm
potassium
phosphat
ph
salt
mm
dtt
vv
h
apo
inhibit
state
activ
site
proteas
concentr
nmr
sampl
vari
depend
experi
perform
indic
data
acquir
bruker
avanc
mhz
mhz
instrument
equip
triplereson
cryoprob
extern
c
n
h
chemic
shift
referenc
perform
previous
report
spectral
data
process
nmrpipe
analyz
sparki
prevent
selfproteolysi
uniformli
c
n
hlabel
apo
cruzain
major
fraction
elut
size
exclus
purif
step
immedi
inhibit
greater
stoichiometr
ratio
vinyl
sulfon
standard
stock
consist
mm
unlabel
inhibitor
dissolv
dmso
cambridg
isotop
laboratori
nmr
sampl
consist
mm
uniformli
c
n
hlabel
complex
ml
nmr
buffer
suit
threedimension
triplereson
experi
use
acquir
backbon
amid
side
chain
carbon
reson
assign
consist
hncacb
hn
co
cacb
hnco
cc
co
nh
n
hnoesyhsqc
acquir
uniformli
n
hlabel
sampl
use
assign
methionin
group
gener
spectral
paramet
acquisit
time
list
support
inform
chemic
shift
assign
list
supplement
tabl
nmr
sampl
use
h
hsqc
h
hsqc
experi
consist
mm
uniformli
select
nhi
nci
cmet
label
cruzain
ml
solut
inhibitor
dissolv
dmso
cambridg
isotop
laboratori
result
mm
stock
solut
titrat
perform
ad
aliquot
mm
stock
solut
stepwis
manner
fold
stoichiometr
excess
respect
cruzain
achiev
total
titrat
point
apo
inhibitor
acquir
nmr
solut
supplement
mm
dtt
final
concentr
prior
acquir
first
apo
titrat
point
final
dmso
concentr
exceed
vv
spectral
paramet
data
process
protocol
report
support
inform
total
chemic
shift
perturb
valu
calcul
previous
describ
circular
dichroism
cd
data
acquir
jasco
spectropolarimet
room
temperatur
use
cm
pathlength
qs
cuvett
singl
scan
rang
nm
acquir
sampl
spectral
paramet
estim
fraction
helic
f
h
valu
previous
describ
concentr
procruzain
stock
mm
potassium
phosphat
buffer
contain
salt
ph
ph
ph
titrat
point
concentr
enzym
stock
dilut
buffer
contain
variou
concentr
guanidinium
hydrochlorid
gdnhcl
final
cruzain
concentr
final
gdnhcl
concentr
assay
solut
rang
procruzain
assay
solut
mix
gentli
pipet
mixtur
incub
room
temperatur
minut
prior
data
acquisit
structur
represent
gener
use
xray
crystal
structur
complex
pdb
access
pymol
version
llc
extens
modif
previous
report
cruzain
express
protocol
provid
suffici
quantiti
purifi
activ
cruzain
use
nmrbase
studi
origin
proteas
construct
express
insolubl
fusion
protein
requir
urea
denatur
multipl
refold
dialysi
step
report
yield
origin
protocol
use
rich
media
mg
fusion
protein
per
liter
bacteri
cultur
result
approxim
mg
activ
cruzain
selfactiv
purif
step
current
protocol
tag
sequenc
place
nterminu
cruzain
construct
figur
eas
purif
nickel
sepharos
column
construct
express
solublefract
zymogen
use
autoinduct
method
describ
studier
compar
origin
inclus
bodi
prepar
use
rich
media
autoinduct
minim
rich
media
signific
improv
yield
zymogen
form
cruzain
mg
per
liter
rich
autoinduct
media
tochowitz
merski
person
commun
mg
per
liter
minim
autoinduct
media
higher
protein
yield
allow
faster
autoactiv
inact
zymogen
catalyt
activ
cruzain
figur
minut
compar
approxim
hour
previou
protocol
result
also
verifi
selfactiv
procruzain
concentr
depend
notabl
incub
procruzain
imped
complet
abolish
vitro
selfactiv
zymogen
figur
support
inform
fluorescencebas
activ
assay
use
peptid
substrat
zpheargamc
data
shown
verifi
cleav
product
activ
form
cruzain
final
yield
purifi
activ
cruzain
mg
per
liter
autoinduct
rich
media
mg
per
liter
autoinduct
minim
media
correspond
n
h
hsqc
spectra
apo
figur
supplement
fig
cruzain
display
welldispers
reson
peak
verifi
presenc
fold
protein
examin
cruzain
n
h
hsqc
spectra
indic
apo
state
highli
suscept
continu
selfproteolysi
current
nmr
condit
spectra
apo
cruzain
acquir
time
interv
period
less
day
exhibit
reson
peak
ppm
h
dimens
present
time
zero
spectrum
data
shown
presenc
peak
grew
intens
period
time
hallmark
protein
degrad
andor
unfold
store
apo
cruzain
sampl
allevi
problem
degrad
peak
also
present
respect
hsqc
spectra
obtain
backbon
side
chain
reson
assign
standard
triplereson
data
set
acquir
use
uniformli
c
n
hlabel
cruzain
inhibit
unlabel
howev
n
h
hsqc
spectra
deuter
complex
exhibit
sever
miss
peak
comparison
proton
analog
supplement
fig
indic
incomplet
h
h
backexchang
amid
proton
protein
purif
attempt
partial
denatur
complex
ph
gdnhcl
follow
rapid
dilut
refold
yield
appreci
amid
proton
back
exchang
observ
hsqc
spectra
data
shown
fortun
result
triplereson
spectra
yield
backbon
amid
side
chain
reson
assign
approxim
nonprolin
residu
complex
supplement
tabl
major
absent
backbon
amid
assign
correspond
residu
central
well
portion
adjac
importantli
except
backbon
amid
reson
residu
locat
within
activ
site
substrat
bind
pocket
complex
assign
provid
suffici
coverag
map
bind
mode
proteas
inhibitor
circular
dichroism
cd
studi
perform
examin
structur
stabil
complex
apo
procruzain
figur
overal
cd
signatur
acquir
absenc
denatur
ph
exhibit
significantli
greater
helic
content
ph
supplement
fig
cd
spectrum
procruzain
ph
acquir
due
signific
protein
aggreg
acid
ph
neutral
condit
ph
cd
signatur
inhibit
cruzain
remain
rel
stabl
increas
denatur
concentr
band
lose
half
signal
gdnhcl
result
explain
lack
h
h
back
exchang
observ
uniformli
label
c
n
h
nmr
sampl
describ
low
denatur
concentr
normal
use
partial
unfold
deuter
protein
convers
ph
complex
becom
structur
labil
greater
gdnhcl
concentr
apoform
procruzain
ph
display
less
structur
stabil
low
gdnhcl
concentr
rel
complex
similar
condit
case
band
apo
procruzain
cd
spectra
neg
complex
gdnhcl
indic
greater
helic
content
howev
gdnhcl
band
procruzain
cd
curv
lost
half
intens
structur
stabil
complex
ph
also
reflect
heteronuclear
noe
data
measur
backbon
mobil
term
noe
ratio
supplement
fig
includ
nand
ctermin
residu
major
backbon
amid
inhibit
proteas
exhibit
noe
ratio
greater
indic
lack
overal
backbon
mobil
region
display
lower
noe
ratio
associ
higher
level
conform
mobil
loop
region
exampl
residu
locat
two
taken
togeth
cd
heteronuclear
noe
studi
indic
complex
extraordinarili
stabl
structur
even
presenc
high
denatur
concentr
structur
acid
condit
select
label
cruzain
nci
nhi
cmet
perform
quickli
assess
potenti
inhibitorproteas
interact
via
nmr
spectroscopi
label
scheme
chosen
sinc
two
catalyt
residu
addit
rel
cystein
eight
histidin
four
methionin
four
residu
within
cruzain
sequenc
welldispers
within
cruzain
structur
figur
respect
hsqc
spectra
supplement
fig
six
eight
cystein
residu
sequest
disulfid
bond
free
cystein
residu
one
buri
central
helic
core
catalyt
surfac
expos
case
crystal
structur
pair
locat
within
catalyt
three
four
histidin
residu
locat
distal
side
molecul
respect
catalyt
although
methionin
residu
posit
greater
activ
site
present
surfaceexpos
substrat
bind
pocket
locat
proxim
loop
importantli
form
portion
pocket
cruzain
bind
pocket
subsit
interact
posit
two
residu
ntermin
scissil
bond
peptid
substrat
known
determin
cystein
cathepsin
enzym
specif
loop
contain
separ
catalyt
cluster
tryptophan
residu
therefor
perturb
conform
upon
inhibitor
bind
may
also
propag
tryptophan
cluster
toward
two
methionin
residu
select
label
cruzain
sampl
titrat
sever
inhibitor
known
bind
mode
proof
principl
list
compound
tabl
previous
identifi
either
chemic
modif
known
peptid
substrat
via
comput
dock
experi
verifi
inhibitori
effect
proteas
activ
cystein
histidin
methionin
residu
segreg
three
categori
accord
respect
distanc
activ
site
activ
site
proxim
remot
activ
site
residu
surfac
expos
locat
substrat
bind
pocket
within
catalyt
thiol
group
proxim
residu
border
activ
site
region
locat
thiol
remain
cyshismet
residu
gener
locat
greater
thiol
categor
remot
coval
irrevers
inhibitorhsqc
titrat
vinyl
sulfon
known
coval
irrevers
inhibitor
yield
dramat
chemic
shift
perturb
peak
correspond
catalyt
residu
residu
locat
within
proxim
activ
site
substrat
bind
pocket
figur
residu
locat
remot
region
display
neglig
shift
perturb
appar
maximum
shift
perturb
reach
low
stoichiometr
inhibitor
ratio
fold
molar
excess
respect
cruzain
significantli
affect
increas
concentr
figur
coval
revers
inhibitorspectr
data
nitril
compound
coval
revers
inhibitor
display
similar
chemic
shift
perturb
profil
observ
titrat
supplement
fig
howev
precipit
format
within
nmr
tube
occur
titrat
compound
sinc
none
hsqc
reson
peak
concurr
broaden
inhibitor
concentr
increas
compound
cruzain
like
precipitatingaggreg
speci
solut
major
differ
overal
perturb
pattern
two
data
set
especi
notic
methionin
may
attribut
differ
chemic
moieti
present
compound
well
rel
posit
enzym
exampl
crystal
structur
cruzaincompound
complex
inhibitor
contact
posit
greater
convers
complex
methionin
methyl
group
contact
inhibitor
moreov
termin
sulfyl
phenyl
ring
contact
allow
conform
perturb
tryptophan
indol
ring
affect
observ
chemic
shift
noncoval
inhibitorsin
comparison
coval
bound
compound
titrat
high
molar
equival
known
noncoval
cruzain
inhibitor
display
significantli
reduc
sometim
neglig
nci
chemic
shift
perturb
supplement
fig
case
nhi
cmet
spectra
catalyt
well
display
strong
chemic
shift
perturb
supplement
fig
gener
shift
perturb
nhi
cmet
reson
reach
maximum
valu
greater
molar
excess
inhibitor
concentr
addit
case
titrat
compound
amid
reson
exhibit
extens
peak
broaden
low
inhibitor
concentr
intens
three
histidin
peak
remain
rel
unchang
broaden
specif
aminoacid
reson
peak
indic
intermedi
nmr
timescal
conform
exchang
rather
protein
aggreg
similar
peak
broaden
observ
catalyt
low
concentr
compound
multipl
peak
like
correspond
degrad
product
also
observ
nci
nhi
hsqc
spectra
compound
titrat
result
confirm
noncoval
inhibitor
overal
weaker
bind
affin
cruzain
coval
counterpart
reflect
micromolar
k
ic
valu
tabl
noninteract
compoundsth
oxadiazol
repres
scaffold
subsequ
consid
noninteract
compound
andor
aggreg
j
ellman
person
commun
titrat
cruzain
sampl
compound
result
aggreg
form
nmr
tube
overal
chemic
shift
perturb
three
report
group
minor
comparison
observ
compound
supplement
fig
interestingli
peak
correspond
catalyt
appear
exchang
broaden
dramat
cystein
histidin
residu
compound
remain
reson
peak
hsqc
spectra
significantli
broaden
cours
titrat
addit
group
reson
among
methionin
residu
perturb
upon
addit
compound
togeth
result
suggest
although
compound
aggreg
solut
may
limit
bind
affin
cruzain
scaffold
list
tabl
previous
unknown
bind
mode
compound
chlorin
intermedi
compound
case
compound
ad
cruzain
nmr
sampl
test
hypothesi
nitril
group
compound
necessari
coval
bind
similarli
compound
titrat
compound
result
precipit
format
solut
case
howev
neglig
effect
reson
shift
perturb
peak
broaden
observ
nci
nhi
hsqc
spectra
supplement
fig
compound
minim
perturb
observ
peak
supplement
fig
direct
comparison
overal
averag
report
group
chemic
shift
perturb
compound
figur
indic
nitril
deriv
interact
strongli
cruzain
chlorin
deriv
thiol
coval
bind
directli
purin
ring
compound
signific
chemic
shift
perturb
par
observ
compound
would
observ
report
group
collect
nmr
titrat
data
suggest
possibl
weak
transient
noncoval
interact
cruzain
compound
nmr
data
also
verifi
previous
report
cruzaincompound
bind
mode
thiol
sulfur
coval
bond
nitril
group
directli
purin
group
inhibitor
tabl
exhibit
bind
inhibitori
constant
low
micromolar
rang
total
sum
averag
nci
nhi
cmet
shift
perturb
largest
coval
bound
inhibitor
compound
smallest
noninteractorsaggreg
figur
expect
competit
inhibitor
design
target
activ
site
residu
locat
within
substrat
bind
site
display
larger
total
averag
chemic
shift
perturb
rel
proxim
remot
residu
except
trend
appear
compound
extens
peak
broaden
catalyt
residu
would
limit
contribut
observ
total
chemic
shift
perturb
maximum
chemic
shift
perturb
catalyt
cystein
histidin
methionin
residu
observ
less
two
fold
excess
compound
rel
cruzain
case
coval
bound
inhibitor
convers
noncoval
inhibitor
greater
fold
excess
compound
requir
appar
maximum
chemic
shift
perturb
reach
comparison
nci
data
supplement
figur
reveal
distinct
pattern
coval
bound
inhibitor
impart
chemic
shift
perturb
catalyt
greater
ppm
noncoval
compound
display
valu
less
ppm
cystein
report
group
case
nhi
data
supplement
figur
chemic
shift
perturb
valu
catalyt
observ
compound
titrat
appear
reach
maximum
valu
fold
excess
compound
signific
differ
fold
excess
inhibitor
convers
although
signific
perturb
observ
upon
addit
equival
noncoval
inhibitor
compound
chang
chemic
shift
reson
observ
fold
excess
similar
pattern
observ
supplement
figur
establish
express
purif
protocol
result
high
yield
activ
cruzain
optim
autoinduct
protocol
assist
complet
recent
crystallographi
effort
also
allow
costeffect
product
isotop
label
cruzain
use
nmr
studi
due
inher
instabl
activ
cruzain
yet
crystal
apo
form
previous
publish
cruzain
sar
studi
reli
obtain
highresolut
xray
crystal
structur
usual
inhibit
proteas
except
compound
none
noncoval
inhibitor
list
tabl
success
cocrystal
cruzain
exist
crystallograph
structur
cruzain
continu
util
silico
dock
model
studi
highthroughput
screen
ht
method
fluoresc
activ
assay
help
triag
compound
librari
order
identifi
potenti
lead
inhibitor
howev
neither
dock
ht
studi
verifi
character
inhibitor
bind
site
allow
thorough
biophys
studi
cruzain
illustr
advantag
select
isotop
label
bind
mode
inhibitor
examin
rel
fast
manner
use
nmrbase
method
particular
use
select
nci
nhi
cmet
label
cruzain
help
quickli
verifi
bind
site
eight
smallmolecul
inhibitor
except
noninteractorsaggreg
titrat
compound
use
cruzain
sampl
perturb
chemic
shift
residu
near
activ
site
importantli
nmr
titrat
verifi
previous
report
silico
dock
result
select
noncoval
bind
compound
includ
exist
crystallograph
data
set
use
current
nmr
autom
technolog
sampl
contain
standard
mm
nmr
tube
binari
bind
experi
ie
apo
versu
greater
fold
excess
compound
perform
hour
per
sampl
rate
data
acquisit
enhanc
use
nmr
flowcel
well
plate
sampl
attach
requir
smaller
sampl
volum
ad
advantag
allow
higher
protein
inhibitor
concentr
rel
standard
mm
tube
importantli
faster
data
acquisit
time
result
nmr
titrat
use
verifi
whether
candid
compound
bind
cruzain
competit
inhibitor
addit
nmrbase
titrat
may
verifi
recent
propos
alloster
bind
site
locat
greater
catalyt
insight
gain
nmr
titrat
potenti
inhibitor
especi
exhibit
weak
bind
affin
cruzain
may
also
help
determin
whether
effort
optim
compound
sar
studi
warrant
although
nmr
titrat
assay
abl
detect
subtl
differ
variou
chemic
scaffold
rel
orient
within
bind
pocket
may
use
determin
differ
chemic
analog
exampl
clear
differ
hsqc
spectra
observ
compound
coval
binder
noninteractoraggreg
share
chemic
scaffold
differ
function
group
attach
purin
ring
nitril
group
compound
chloro
group
compound
case
nmr
spectroscopi
xray
crystallographi
use
conjunct
identifi
optim
potenti
therapeut
lead
cruzain
intens
longstand
interest
cystein
proteas
particularli
due
involv
wide
rang
human
diseas
particular
cystein
cathepsin
make
canon
cathepsin
famili
member
known
play
role
extracellular
matrix
remodel
human
lead
develop
variou
patholog
includ
cancer
cardiovascular
inflammatori
diseas
howev
rel
nmrbase
studi
focu
catalyt
domain
one
earli
effort
focus
ph
studi
activ
papain
reli
onedimension
proton
spectra
second
studi
present
twodimension
nmr
data
zymogen
procathepsin
l
report
use
reson
assign
major
previou
nmrbase
structur
calcul
center
protein
inhibitor
chagasin
cruzain
cathepsin
l
recent
nmrbase
structur
studi
focus
cystein
proteas
streptopain
foot
mouth
diseas
viru
leader
proteas
ubiquitin
ctermin
hydrolas
sar
coronaviru
main
proteas
sar
cov
pro
appear
literatur
importantli
enzym
construct
catalyt
cystein
substitut
either
serin
alanin
case
sar
cov
pro
truncat
render
proteas
inact
date
exampl
activ
papainlik
cystein
proteas
extens
studi
via
nmr
includ
josephin
domain
domain
lipoprotein
spr
sortas
proteas
contain
catalyt
cystein
histidin
residu
posit
approxim
rel
posit
papain
howev
low
overal
sequenti
structur
homolog
backbon
rmsd
respect
papain
member
cathepsin
cystein
proteas
famili
thu
knowledg
data
present
herein
repres
first
nmrbase
studi
focus
matur
activ
form
papaincathepsinlik
cystein
proteas
wildtyp
state
basic
level
product
nmrreadi
cruzain
allow
extens
studi
structurefunct
relationship
exampl
backbon
dynam
zymogen
matur
cruzain
examin
order
fulli
understand
conform
mobil
influenc
proteolyt
activ
addit
select
label
sampl
may
also
util
determin
pk
valu
residu
catalyt
support
inform
supplement
fig
inform
may
use
dissect
mechan
enzym
insight
mechan
vitro
procruzain
selfactiv
provid
observ
imped
complet
abolish
cleavag
proregion
catalyt
domain
examin
structur
homolog
variant
procathepsin
l
backbon
rmsd
catalyt
domain
show
short
helix
posit
orthogon
activ
site
occlud
catalyt
residu
howev
residu
immedi
preced
nterminu
catalyt
domain
lie
substrat
bind
cleft
rel
unstructur
suggest
member
papaincathepsin
cystein
proteas
famili
proregion
cruzain
may
likewis
adopt
similar
conform
mode
autoinhibit
rel
unstructur
state
proregion
may
allow
transient
interact
catalyt
domain
turn
allow
activ
site
expos
catalyt
compet
state
activ
enzym
avail
would
readi
proteolyz
procruzain
molecul
initi
cascad
autoactiv
event
express
purif
strategi
describ
herein
may
also
adapt
papain
eleven
known
structur
homolog
cystein
cathepsin
open
possibl
character
solut
state
via
nmr
spectroscopi
biophys
method
exampl
recent
demonstr
inhibit
activ
cathepsin
b
l
isol
pancreat
extract
result
studi
could
understand
mechan
govern
enzymat
activ
well
assist
discoveri
new
inhibitor
larg
famili
close
relat
cystein
proteas
circular
dichroism
denatur
studi
procruzain
minim
perturb
cd
spectra
complex
guanidinium
hydrochlorid
gdnhcl
final
concentr
color
indic
measur
ph
b
ph
c
ph
reflect
structur
stabil
inhibit
proteas
chemic
denatur
cd
spectra
procruzain
absenc
inhibitor
measur
ph
indic
weaker
overal
stabil
gdnhcl
denatur
final
concentr
color
indic
comparison
band
estim
fraction
helic
data
display
supplement
figur
choos
cystein
histidin
methionin
residu
cruzain
inhibitor
bind
probe
distribut
cystein
yellow
ball
b
histidin
cyan
ball
c
methionin
orang
magenta
ball
residu
map
crystal
structur
complex
pdb
catalyt
dark
blue
red
cyan
residu
indic
box
put
catalyt
residu
omit
clariti
orang
locat
surfac
substrat
bind
pocket
rel
unstructur
ntermin
region
residu
brown
cartoon
also
indic
cruzain
activ
site
repres
rotat
horizont
axi
respect
part
ac
posit
catalyt
blue
red
cyan
green
amid
group
indic
ball
orang
ball
denot
posit
group
purpl
ball
denot
posit
group
cluster
tryptophan
residu
dark
red
brown
pink
connect
light
green
form
portion
pocket
also
display
van
der
waal
surfac
tryptophan
cluster
indic
mesh
surfac
represent
cruzain
activ
site
e
without
f
structur
residu
color
part
chemic
shift
perturb
data
cruzain
report
group
hsqc
titrat
spectra
select
label
nci
b
nhi
cmet
cruzain
black
red
molar
equival
solid
box
indic
residu
locat
substrat
bind
pocket
dot
line
correspond
perturb
residu
chemic
shift
perturb
rel
apo
state
black
red
molar
equival
observ
select
label
nci
e
